Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Arch Neurol. 2011 Apr;68(4):488–497. doi: 10.1001/archneurol.2011.53

Table 4.

Clinical Features of the c.1477C>T (p.R493X) GRN Mutation Compared With Other GRN Mutations

Characteristic c.1477C>T (p.R493X) (n=18) Other GRN Mutations (n=79) P Valuea
Age at onset, median (IQR), y 57.0 (50.5-61.0) 58.5 (53.0-65.0) .12
Age at death, median (IQR), y 64.0 (55.5-68.5) 66.0 (61.0-73.0) .10
Disease duration, median (IQR), y 5.0 (3.0-9.0) 7.0 (5.0-8.0) .89
Male sex, No. (%) 13/18 (72.2) 35/79 (44.3) .04
Family history, No. (%) 9/15 (60.0) 50/63 (79.4) .18
MND, No. (%) 0 9/76 (11.8) .20
PD/CBS/PSP, No. (%) 0 5/77 (6.5) .58

Abbreviations: CBS, corticobasal syndrome; IQR, interquartile range; MND, motor neuron disease; PD, Parkinson disease; PSP, progressive supranuclear palsy.

a

P values determined by log-rank testing for continuous variables and Fisher exact testing for categorical variables. Significant values are given in boldface type.